Madrigal Pharmaceuticals, Inc.
NASDAQ:MDGL
242.25 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.147 | 7.584 | 14.803 | 144.245 | 2.615 | 0.743 | 0 | 0 | 0.173 | 1.304 | 0 | 0 |
| Cost of Revenue
| 0.527 | 0.467 | 0.405 | 0.471 | 0.112 | 0.096 | 0.077 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.527 | -0.467 | -0.405 | -0.471 | -0.112 | -0.096 | -0.077 | -0 | 0 | 0 | 0 | 0.147 | 7.584 | 14.803 | 144.245 | 2.615 | 0.743 | 0 | 0 | 0.173 | 1.304 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 |
| Reseach & Development Expenses
| 271.823 | 245.441 | 205.164 | 184.809 | 72.324 | 25.389 | 24.39 | 15.934 | 54.218 | 68.205 | 71.86 | 49.412 | 41.464 | 40.252 | 51.054 | 81.581 | 52.025 | 50.503 | 59.901 | 38.136 | 24.337 | 7.292 | 0.277 |
| General & Administrative Expenses
| 108.146 | 48.13 | 37.318 | 21.864 | 22.648 | 15.293 | 7.672 | 9.29 | 13.392 | 15.746 | 15.699 | 11.676 | 11.552 | 11.449 | 12.651 | 14.742 | 14.934 | 8.648 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 108.038 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 108.146 | 48.13 | 37.318 | 21.864 | 22.648 | 15.293 | 7.672 | 9.29 | 13.392 | 15.746 | 15.699 | 11.676 | 11.552 | 11.449 | 12.651 | 14.742 | 14.934 | 8.648 | 11.279 | 7.383 | 5.261 | 0 | 0.124 |
| Other Expenses
| 0 | 0 | 0.273 | 0.1 | 0 | 0.2 | 0.35 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.236 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 379.969 | 293.571 | 242.482 | 206.673 | 94.972 | 40.682 | 32.062 | 25.224 | 67.61 | 83.951 | 87.559 | 61.088 | 53.016 | 51.701 | 63.705 | 96.323 | 66.959 | 59.151 | 71.18 | 45.519 | 29.598 | 7.292 | 0.401 |
| Operating Income
| -380.496 | -293.571 | -242.482 | -206.673 | -94.972 | -40.682 | -32.062 | -25.224 | -67.61 | -83.951 | -87.559 | -60.941 | -45.432 | -36.898 | 79.304 | -93.708 | -66.216 | -59.151 | -71.18 | -46.929 | -28.294 | -36.264 | -0.401 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -414.565 | -5.991 | -2.493 | 0.55 | -35.835 | -89.12 | 0 | 0 | -271.266 | -21.698 | 0 | 0 |
| Total Other Income Expenses Net
| 6.866 | -1.779 | 0.636 | 4.429 | 11.024 | 0.2 | 0.35 | -1.164 | -1.061 | -2.21 | -2.633 | -1.849 | -1.948 | -0.569 | -1.236 | 1.09 | 2.721 | 1.881 | 2.317 | -0.588 | 0.416 | -18.088 | 0 |
| Income Before Tax
| -373.63 | -295.35 | -241.846 | -202.244 | -83.948 | -32.811 | -31.154 | -26.388 | -68.671 | -86.161 | -90.192 | -62.79 | -47.38 | -37.467 | 79.088 | -92.618 | -122.08 | -59.129 | -68.863 | -47.517 | -27.878 | -54.352 | 0 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -427.143 | -6.247 | -2.531 | 0.548 | -35.418 | -164.307 | 0 | 0 | -274.665 | -21.379 | 0 | 0 |
| Income Tax Expense
| 0 | 3.964 | -0.768 | -4.8 | -11.136 | 7.871 | -0.635 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.452 | 0 | -2.721 | -1.881 | -2.317 | 0.588 | -0.416 | -18.198 | 0.381 |
| Net Income
| -373.63 | -299.314 | -241.078 | -197.444 | -72.812 | -32.811 | -31.154 | -26.388 | -68.671 | -86.161 | -90.192 | -62.79 | -47.38 | -37.467 | 79.088 | -92.618 | -63.495 | -57.27 | -68.863 | -45.934 | -27.878 | -36.154 | -0.381 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -427.143 | -6.247 | -2.531 | 0.548 | -35.418 | -85.458 | 0 | 0 | -265.514 | -21.379 | 0 | 0 |
| EPS
| -19.99 | -17.47 | -14.58 | -12.78 | -4.73 | -2.22 | -2.54 | -5.07 | -401.56 | -30.62 | -44.48 | -36.99 | -35.14 | -32.49 | 81.55 | -96.09 | -68.45 | -90.03 | -108.31 | -85.96 | -44.65 | -105.09 | -4.55 |
| EPS Diluted
| -19.99 | -17.47 | -14.58 | -12.78 | -4.73 | -2.22 | -2.54 | -5.07 | -401.56 | -30.62 | -44.48 | -36.99 | -35.14 | -32.49 | 81.2 | -96.09 | -68.45 | -90.03 | -108.31 | -85.96 | -44.65 | -105.09 | -4.55 |
| EBITDA
| -379.969 | -291.386 | -242.482 | -206.673 | -94.972 | -40.682 | -32.062 | -25.224 | -66.948 | -83.278 | -87.043 | -60.203 | -43.968 | -34.965 | 84.239 | -90.991 | -65.586 | -57.377 | -71.042 | -43.211 | -27.704 | 10.796 | -0.401 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -409.544 | -5.797 | -2.362 | 0.584 | -34.796 | -88.272 | 0 | 0 | -249.775 | -21.245 | 0 | 0 |